By: SharpBrains

Source: Express Scripts
_____
Express Scripts Launches First Digital Health Formulary for Apps & Devices (HIT Consultant):
“Starting in January 2020, Express Scripts Digital Health Formulary will initially include 15 solutions for remote monitoring services and digital therapeutics that aid in the management of eight of the country’s most common chronic conditions: diabetes, prediabetes, hypertension, asthma, pulmonary disease, depression, anxiety, and insomnia Read the rest of this entry »
By: SharpBrains

_____
Time to wrap-up another very active month with our SharpBrains e‑newsletter summarizing exciting developments in brain research, healthcare and technology — plus a couple fun brain teasers to spark curiosity and innovation 🙂
New brain research:

New thinking about brain & mental health:
Emerging neurotech and digital brain health:
Finally, a couple fun brain teasers:
Have a excellent Halloween…
The SharpBrains Team
By: SharpBrains
_______________
As Sandoz returns marketing rights for digital therapeutics to Pear, what does it mean for co-promote arrangements? (MM&M):
“Sandoz, the generics division of Novartis, is altering commercial course, returning marketing duties for two prescription digital therapeutics (DTx) back to Pear Therapeutics. The move, which some had anticipated, comes 18 months after the two signed a co-promotion deal.
Since the Sandoz/Pear pact was widely seen as a litmus test of sorts for pharma’s role in helping distribute this nascent technology, the commercial break-up raises questions about the viability of such partnerships going forward. It also highlights the parties’ sometimes conflicting priorities: Read the rest of this entry »
By: Alvaro Fernandez
_______________
Ana Maiques, CEO and founder of neurotech company Neuroelectrics, writes up a compelling case in her recent article, summarized thus:
“I strongly believe that Neurotech entrepreneurs can not afford not to be involved in neuroethics. It is simply not an option anymore.”
I share that belief and would like to take it one step further:
“I strongly believe that healthcare practitioners, researchers, executives and regulators can not afford not to be involved in neuroethics. It is simply not an option anymore.”
Read the rest of this entry »
By: SharpBrains
_______________
Bayer inks deals with eleven startups under G4A Digital Health Partnerships program (press release):
“Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations to drive forward the development of specific digital solutions to improve patients’ health Read the rest of this entry »